BiotechTV

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Tune in to BiotechTV's coverage of biotech's biggest week of the year! Our full crew will be blanketing Union Square: Brad Loncar - Biopharma CEO Interviews Amy Brown - Biopharma CEO Interviews Ryan Flinn - AI in Biotech Chloe Kirk, Ph.D. - The Next Generation of Biotech Leaders Coverage brought to you by HSBC Innovation Banking. Featuring: Marc de Garidel | Abivax Vlad Coric, M.D. | Biohaven Clay Thorp | Hatteras Venture Partners Andrew Cavey | ITM Brian Skorney | Baird Katherine Andersen | HSBC Innovation Banking John Evans | Beam Brent Saunders | Bausch + Lomb Nicole K. Paulk, PhD | Siren Biotechnology Noubar Afeyan | Flagship Pioneering Claire Brown | Oxford Science Enterprises Kinam Hong | Sofinnova Partners Chris Garabedian | Perceptive Advisors Adrian Woolfson | Genyro Stef van Greiken | Cradle Nijat Ahmadov | Nucs AI Thomas Clozel | OWKIN Linda Marban | Capricor Kevin Parker | Cartography Biosciences Robert Duggan | Summit Therapeutics Maky Zanganeh | Summit Therapeutics Yvonne Greenstreet | Alnylam Therapeutics Neil Kumar | BridgeBio Patrick Soon-Shiong | ImmunityBio Tim Van Hauwermeiren | argenx Karen Massey | argenx Michael Davidson | New Amsterdam Dominik Schumacher | Tubulis Aaron Morris | PostEra Jennifer Carter | Medztown David Dodd | GeoVax Will Lewis | Insmed Naoki Okamura | Astellas Pharma Anish Bhatnagar | Soleno Therapeutics Paul Bolno | Wave Life Sciences Najat Khan, PhD | Recursion Bill Sibold | Madrigal Pharmaceuticals Andy Plump | Takeda Trevor Martin | Mammoth Biosciences Julia Owens | Biotech CEO Sisterhood Sheila Gujrathi, MD | Biotech CEO Sisterhood Angie You | Biotech CEO Sisterhood Kyle W. Gano | Neurocrine Biosciences Paul Romness | OS Therapies Keting Chu | Bluejay Therapeutics Shehnaaz Suliman, M.D., M.B.A., M.Phil. | Recode Therapeutics Heather Turner | LB Pharmaceuticals Steve Harr | Sana Biotechnologies Robert Blum | Cytokinetics Jack O'Meara | Aerska And more... BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Klein Hersh | Savills North America | Genezen | Evaluate Ltd

𝟐𝟎𝟐𝟓 𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: Every year at this time, HSBC Innovation Banking's Jonathan Norris publishes his widely-read full year venture report. DOWNLOAD THE FREE REPORT HERE: https://lnkd.in/eMWu6Uq4 The Full-Year 2025 Venture Healthcare Report is full of metrics that explain the health of venture including: 1. What venture deals got done last year. 2. Who are the most active venture investors. 3. The fundraising and IPO environment. 4. Key technologies and indications. 5. Much more...

𝐆𝐞𝐧𝐞𝐳𝐞𝐧: When therapies are as important to patients as cell and gene therapies, it is important to choose the right CMC partner from the start. As Chairman & CEO Steve Favaloro describes, Genezen has been successfully partnering with companies both large and small, and would love to partner with you. Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art viral vector facilities in Lexington, MA and Indianapolis, IN. If you need help with your AAV, LVV or RVV project, please reach out! Learn more: https://www.genezen.com/

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲: Mizuho Senior Biotech Analyst Salim Syed highlights key companies in the news he covers heading into the new year. Full video: https://lnkd.in/eJT6Vd-k He discusses BridgeBio, Cytokinetics, Vaxcyte, Biogen, and Arcus Biosciences BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Klein Hersh | Savills North America | Genezen | Evaluate Ltd

Thank you for watching BiotechTV in 2025! We are grateful to our viewers, and those who contribute content: Chris Garabedian Biotech CEO Sisterhood Matthew Gline MassBio Our great team: Amy Brown Ryan Flinn Chloe Kirk, Ph.D. Brad Loncar And a special thank you to our sponsors who make it possible: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Klein Hersh | Savills North America | Genezen | Evaluate Ltd

𝐏𝐥𝐞𝐚𝐬𝐞 𝐣𝐨𝐢𝐧 𝐮𝐬: All are welcome! SF Hangout during #JPM26. Tuesday, January 13th at Persona, 685 Sutter Street. 7:00PM to 10:00PM. RSVP here: https://lnkd.in/eUSHfs2g Co-Hosted by: Biotech Hangout and BiotechTV.

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲: William Blair senior biotech analyst Andy Hsieh gives an overview of the obesity space heading into 2026 - including his opinion of the new Wegovy pill. Full interview: https://lnkd.in/efqrYVcr He discusses the recently approved Wegovy pill, and compares and contrasts it to other oral programs from Lilly, Structure, and Corbus. Plus, how is the amylin space looking compared to GLP-1s, and a preview of Viking's 2026. BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Klein Hersh | Savills North America | Genezen | Evaluate Ltd

𝐆𝐞𝐧𝐞𝐳𝐞𝐧: Sheyla Mirabal, Principal Scientist - Analytical Development Lead at Genezen’s Lexington, MA facility, shows us some of the analytical equipment involved in making AAV viral vectors for gene therapies. Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art facilities in Lexington, MA and Indianapolis, IN. If you neeed help with your AAV, LVV, or RVV project, please reach out.

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲: A deep dive discussion on Abivax with Truist Securities Senior Biotech Analyst Gregory Renza. Watch the full video: https://lnkd.in/eHw_SqmM We discuss the upcoming maintenance data, commercial prospects, Crohn's, and buyout prospects. BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Klein Hersh | Savills North America | Genezen | Evaluate Ltd